跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
王 莉萱
教授
,
臨床藥學學科
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
藥師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0001-8047-5310
電子郵件
shiuan
tmu.edu
tw
h-index
728
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2001
2024
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(52)
資料集
(7)
類似的個人檔案
(6)
指紋
查看啟用 Li-Hsuan Wang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Statin (Protein)
36%
Pharmacokinetics
36%
Hyperlipidemia
32%
Gastrointestinal Disease
26%
Antilipemic Agent
23%
Prostate Cancer
21%
Levodopa
20%
Case-Control Study
17%
Defined Daily Dose
16%
Malignant Neoplasm
16%
Ischemic Heart Disease
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Drug Interaction
14%
Gout
14%
Non Insulin Dependent Diabetes Mellitus
14%
Proton Pump Inhibitor
14%
Leporidae
13%
Liver Cell Carcinoma
13%
Zolpidem
13%
Hyperthyroidism
13%
Caffeic Acid
13%
Crohn's Disease
13%
Androgen
13%
Fibric Acid Derivative
13%
Dexamethasone
12%
Bioavailability
11%
Diabetes Mellitus
11%
Aspergillus Niger
8%
Periodontitis
8%
Ferulic Acid
8%
Low Birth Weight
8%
Glucocorticoid
8%
Luciferase
8%
Sjoegren Syndrome
8%
High Performance Liquid Chromatography
7%
Coronary Artery Disease
7%
Olanzapine
7%
Atrial Fibrillation
7%
Allopurinol
6%
Atopic Dermatitis
6%
Gonadorelin Derivative
6%
Rikkunshito
6%
Pain
6%
Sprague Dawley Rat
6%
Age Related Macular Degeneration
6%
Transcription Factor AP 1
6%
Paclitaxel
6%
HIV
6%
Ankylosing Spondylitis
6%
Medicine and Dentistry
Cohort Analysis
21%
Statin
20%
Gastrointestinal Disease
19%
Case-Control Study
15%
Retrospective Cohort Study
15%
Maturity Onset Diabetes of the Young
14%
Prostate Cancer
14%
Human Immunodeficiency Virus
13%
Bell's Palsy
13%
Hazard Ratio
13%
Proton-Pump Inhibitor
12%
Cancer Risk
11%
Diabetes Mellitus
10%
Malignant Neoplasm
9%
Ischemic Heart Disease
8%
Apoplexy
8%
Patient with Type 2 Diabetes
7%
Antiretroviral Therapy
7%
Dose Response
7%
Glycon
7%
Hepatocellular Carcinoma
6%
Opportunistic Infection
6%
Zolpidem
6%
Cancer Risk Reduction
6%
Gonadorelin Agonist
6%
Pain
6%
Ankylosing Spondylitis
6%
Androgen Deprivation Therapy
6%
Ephedrine
6%
Interstitial Cystitis
6%
Cystalgia
6%
Acute Pancreatitis
6%
Rheumatoid Arthritis
6%
Cancer Prevention
6%
Mitral Valve Prolapse
6%
Open Angle Glaucoma
6%
Otorhinolaryngology
6%
Thiazolidinedione
6%
Activator Protein 1
6%
Medicine
6%
Lactone
6%
Hyperthyroidism
6%
Low Birth Weight
6%
Small for Gestational Age
6%
Premature Labor
6%
Antithyroid Agent
6%
Odds Ratio
6%
Proportional Hazards Model
5%
Congenital Malformation
5%
Receptor Antagonist
5%
Nursing and Health Professions
Cohort Analysis
15%
Confidence Interval
13%
Human Immunodeficiency Virus
13%
Liver Cell Carcinoma
13%
Gastrointestinal Disease
13%
Hazard Ratio
11%
Case-Control Study
8%
Antiretroviral Therapy
7%
Treatment Outcome
7%
Malignant Neoplasm
7%
Hyperlipidemia
7%
Proton Pump Inhibitor
6%
Antilipemic Agent
6%
Ephedrine
6%
Chronic Hepatitis B
6%
Cancer Prevention
6%
Opportunistic Infection
6%
Antimicrobial Therapy
6%
Bell's Palsy
6%
Cystitis
6%
Liver Cirrhosis
6%
Statin (Protein)
6%
Practice Guideline
6%
Age Related Macular Degeneration
6%
Non Insulin Dependent Diabetes Mellitus
6%
Patient with Type 2 Diabetes
6%
Beta Adrenergic Receptor Blocking Agent
6%
Diabetes Mellitus
6%
Shared Decision-Making
6%
